Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein phosphatase 1 regulatory subunit 3F (PPP1R3F) is a glycogen-targeting regulatory subunit for protein phosphatase 1 (PP1), a major serine/threonine phosphatase that regulates numerous cellular processes[2][3][5]. PPP1R3F is primarily expressed in brain astrocytes and localizes to the endoplasmic reticulum, where it anchors the PP1 catalytic subunit for precise control of glycogen metabolism in neural cells[3][4]. The subunit directs PP1 to dephosphorylate enzymes such as glycogen synthase and glycogen phosphorylase, thus playing an essential role in maintaining brain glycogen levels, especially under fluctuating glucose conditions[3][4]. Genetic variants in PPP1R3F are associated with a novel X-linked neurodevelopmental disorder characterized by developmental delay, intellectual disability, autism spectrum features, and seizures[3][4][5]. Additionally, PPP1R3F gene methylation is associated with increased colorectal cancer risk, highlighting its relevance as a potential epigenetic biomarker[2]. As a regulatory (non-catalytic) protein, PPP1R3F modulates the localization and substrate specificity of PP1 but is not itself a receptor, enzyme, or transporter in the classical sense[2][3][5]. No approved drugs target PPP1R3F directly; however, its role in central nervous system metabolism and disease biology continues to be elucidated.
Regulation of PP1 catalytic subunit localization and activity; modulating dephosphorylation of glycogen-metabolism enzymes (e.g., glycogen synthase and glycogen phosphorylase) via scaffolding/targeting; indirectly modifiable by protein kinase A (PKA)–mediated phosphorylation of the subunit, disrupting its interaction with PP1
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 1 regulatory subunit 3F (PPP1R3F).